This is lecture

Created using ChatSlide

From the discovery of proglucagon and GLP-1’s insulinotropic activity to today’s advanced agonists, this keynote traces the evolution of GLP-1 research into a powerful therapeutic platform. It examines how GLP-1 receptor biology extends beyond glucose control, connecting metabolism with obesity, cardiovascular disease, and other multisystem conditions. By highlighting the milestones that transformed peptide biology into clinical innovation, the presentation offers a concise perspective on why...